Literature DB >> 17520686

Differential expression of both extracellular and intracellular proteins is involved in the lethal or nonlethal phenotypic variation of BrtlIV, a murine model for osteogenesis imperfecta.

Antonella Forlino1, Chiara Tani, Antonio Rossi, Anna Lupi, Elena Campari, Benedetta Gualeni, Laura Bianchi, Alessandro Armini, Giuseppe Cetta, Luca Bini, Joan C Marini.   

Abstract

This study used proteomic and transcriptomic techniques to understand the molecular basis of the phenotypic variability in the bone disorder osteogenesis imperfecta (OI). Calvarial bone mRNA expression was evaluated by microarray, real-time, and comparative RT-PCR and the bone proteome profile was analyzed by 2-DE, MS, and immunoblotting in the OI murine model BrtlIV, which has either a moderate or a lethal OI outcome. Differential expression analysis showed significant changes for eight proteins. The expression of the ER stress-related protein Gadd153 was increased in lethal mice, whereas expression of the chaperone alphaB crystallin was increased in nonlethal mice, suggesting that the intracellular machinery is involved in the modulation of the OI phenotype. Furthermore, in lethal BrtlIV, the increased expression of the cartilaginous proteins Prelp, Bmp6, and Bmp7 and the lower expression of the bone matrix proteins matrilin 4, microfibril-associated glycoprotein 2, and thrombospondin 3 revealed that both a delay in skeletal development and an alteration in extracellular matrix composition influence OI outcomes. Differentially expressed proteins identified in this model offer a starting point for elucidating the molecular basis of phenotypic variability, a characteristic common to many genetic disorders. The first reference 2-DE map for murine calvarial tissue is also reported.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17520686     DOI: 10.1002/pmic.200600919

Source DB:  PubMed          Journal:  Proteomics        ISSN: 1615-9853            Impact factor:   3.984


  24 in total

Review 1.  Chaperoning osteogenesis: new protein-folding disease paradigms.

Authors:  Elena Makareeva; Nydea A Aviles; Sergey Leikin
Journal:  Trends Cell Biol       Date:  2010-12-21       Impact factor: 20.808

Review 2.  Genetic diseases of connective tissues: cellular and extracellular effects of ECM mutations.

Authors:  John F Bateman; Raymond P Boot-Handford; Shireen R Lamandé
Journal:  Nat Rev Genet       Date:  2009-03       Impact factor: 53.242

3.  Molecular Consequences of the SERPINH1/HSP47 Mutation in the Dachshund Natural Model of Osteogenesis Imperfecta.

Authors:  Uschi Lindert; Mary Ann Weis; Jyoti Rai; Frank Seeliger; Ingrid Hausser; Tosso Leeb; David Eyre; Marianne Rohrbach; Cecilia Giunta
Journal:  J Biol Chem       Date:  2015-05-24       Impact factor: 5.157

Review 4.  New perspectives on osteogenesis imperfecta.

Authors:  Antonella Forlino; Wayne A Cabral; Aileen M Barnes; Joan C Marini
Journal:  Nat Rev Endocrinol       Date:  2011-06-14       Impact factor: 43.330

Review 5.  Bone composition: relationship to bone fragility and antiosteoporotic drug effects.

Authors:  Adele L Boskey
Journal:  Bonekey Rep       Date:  2013-12-04

6.  Impaired osteoblastogenesis in a murine model of dominant osteogenesis imperfecta: a new target for osteogenesis imperfecta pharmacological therapy.

Authors:  Roberta Gioia; Cristina Panaroni; Roberta Besio; Giovanni Palladini; Giampaolo Merlini; Vincenzo Giansanti; Ivana A Scovassi; Simona Villani; Isabella Villa; Anna Villa; Paolo Vezzoni; Ruggero Tenni; Antonio Rossi; Joan C Marini; Antonella Forlino
Journal:  Stem Cells       Date:  2012-07       Impact factor: 6.277

7.  Differential response to intracellular stress in the skin from osteogenesis imperfecta Brtl mice with lethal and non lethal phenotype: a proteomic approach.

Authors:  Laura Bianchi; Assunta Gagliardi; Roberta Gioia; Roberta Besio; Chiara Tani; Claudia Landi; Maria Cipriano; Anna Gimigliano; Antonio Rossi; Joan C Marini; Antonella Forlino; Luca Bini
Journal:  J Proteomics       Date:  2012-02-18       Impact factor: 4.044

8.  Cellular mechanism of decreased bone in Brtl mouse model of OI: imbalance of decreased osteoblast function and increased osteoclasts and their precursors.

Authors:  Thomas E Uveges; Patricia Collin-Osdoby; Wayne A Cabral; Felicia Ledgard; Leah Goldberg; Clemens Bergwitz; Antonella Forlino; Philip Osdoby; Gloria A Gronowicz; Joan C Marini
Journal:  J Bone Miner Res       Date:  2008-12       Impact factor: 6.741

9.  Makings of a brittle bone: Unexpected lessons from a low protein diet study of a mouse OI model.

Authors:  E L Mertz; E Makareeva; L S Mirigian; K Y Koon; J E Perosky; K M Kozloff; S Leikin
Journal:  Matrix Biol       Date:  2016-03-31       Impact factor: 11.583

Review 10.  The unfolded protein response and its relevance to connective tissue diseases.

Authors:  Raymond P Boot-Handford; Michael D Briggs
Journal:  Cell Tissue Res       Date:  2009-10-23       Impact factor: 5.249

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.